You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Claims for Patent: 10,098,877


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,098,877
Title:Methods and compositions for treating diabetes, metabolic syndrome and other conditions
Abstract: Pharmaceuticals compositions comprising the 2S, 4R, ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2R, 4S ketoconazole enantiomer are useful to reduce cortisol synthese and for the treatment of type 2 diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other diseases and conditions, including but not limited to Cushing's Syndrome, depression, and glaucoma.
Inventor(s): Marin; Per (Vastra Frolunda, SE)
Assignee: Strongbridge Ireland Limited (Trevose, PA)
Application Number:15/886,437
Patent Claims: 1. A method for treating Cushing's Syndrome in a patient in need of such treatment, said method comprising administering a therapeutically effective amount of a composition comprising a ketoconazole component to said patient, wherein at least 90% of the ketoconazole component is comprised of the 2S,4R ketoconazole enantiomer, wherein the effective amount of the 2S,4R ketoconazole enantiomer is from about 50 mg to about 600 mg.

2. A method for treating Cushing's Syndrome in a patient in need of such treatment, said method comprising administering a therapeutically effective amount of a composition comprising a ketoconazole component to said patient, wherein at least 95% of the ketoconazole component is comprised of the 2S,4R ketoconazole enantiomer, wherein the effective amount of the 2S,4R ketoconazole enantiomer is from about 50 mg to about 600 mg.

3. A method for treating Cushing's Syndrome in a patient in need of such treatment, said method comprising administering a therapeutically effective amount of a composition comprising a ketoconazole component to said patient, wherein at least 99% of the ketoconazole component is comprised of the 2S,4R ketoconazole enantiomer, wherein the effective amount of the 2S,4R ketoconazole enantiomer is from about 50 mg to about 600 mg.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.